Full-Time

Senior Manager

Operations

Posted on 2/21/2026

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Cork, Ireland

In Person

Category
Operations & Logistics (1)
Required Skills
Inventory Management
Requirements
  • At least 5 years manufacturing experience, preferably at production management level, within a team-based manufacturing environment.
  • Degree in Mechanical Production Engineering or equivalent essential.
  • An excellent team player that can leverage the abilities of all personnel working within the business unit.
  • Competent in preparing business strategies and implementing action plans.
  • PC literate and strong knowledge of inventory systems, material requirements planning, and measurement tools.
  • Excellent presentation and communication skills are required.
  • Individual must be challenged by a team-based environment, which places high degree of emphasis on accountability for service levels, inventory management, standard cost, expense control and quality/GMP compliance.
  • Strong leadership skills, persuasive but firm and decisive when necessary, and can demonstrate success in managing change, developing the team, and confronting performance issues (experience in a unionized environment an advantage but not essential).
  • Travel Percentage: 10%
  • Medical Device background is desirable but not essential.
Responsibilities
  • Day-to-day effective management of production, ensuring products are produced in a timely and cost-effective manner.
  • Lead teams to deliver a quality first culture, customer service, enabling growth, continuous improvement of products and processes and drive engagement of the operations teams, while ensuring alignment to Stryker Corporate and SGS requirements and standards.
  • Mentor to other Operations Managers.
  • Establish performance targets for the Business Unit(s), and monitor actual Business Unit performance against targets, taking appropriate and timely corrective action where negative trends begin to emerge.
  • Leadership of one or multiple high performing teams across units, provides guidance / direction to the operational and functional areas on site, fostering an environment of proactive and continuous improvement approach.
  • Mentors and coaches other Operations Managers.
  • Ensure that sufficient processes are in place for capacity planning so the organisation’s commitment to meets or exceeds customer requirements are met.
  • Sponsors an environment of Safety, Quality, People Development and CI within Stryker by working with business partners to define expected standards and the roles/responsibilities in the conservation of these standards.
  • Champions a positive employee environment by promoting open communication, engagement, and development of quality teams. Promotes a culture of inclusiveness, trust, flexibility, and teamwork.
  • Ensures effective processes in selection of competent talent and supports the development of future potential experts and leaders. Ensures effective training and performance management processes are in place and executed.
  • Sponsors and ensures engagement in all internal and external audit programmes such as Corporate, notified body & FDA audits.
  • Oversight and responsibility to ensure operation units maintains adherence to all KPI’s (Safety, Quality, Service, Cost, and People Development). Continuously monitors and partakes in Local and global forums to assess opportunities for improvement.
  • With global alignment, ensures that necessary Capacity is in place across the network to meet our Customers’ Demands.
  • Represent the Operations function in NPI launches, ensuring availability of resources and FG product to meet agreed launch plans.
  • Foster strong collaboration across all functions, has a strategic view in identifying alignment and developing strategies.
  • Contribute as a key member of SYK Site Management Team to develop and implement an operational execution plan for the site
  • Build a high trust and engagement culture within operations. Lead and demonstrate behaviors that drive engagement every day.
  • Build and develop talent within the function and site. Support and mentor other team members as required and participate in talent review process outside of own area
  • Ensure effective performance management, communications, and recognition within function.
  • Supporting and / or managing major CI Programs as required, which may include being involved at any or all phases of project / program from idea to execution phase.
  • Project manage the more complex improvement initiatives as required
  • Support Standardising approaches and practices across Operations Locally and Globally.
  • All other duties as required
Desired Qualifications
  • Medical Device background desirable but not essential

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE